Carotid Plaque 不稳定性和大脑动脉栓塞:中风预防的未来方向
Ulf Hedin1,2, Eva Karlöf1,2
1Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Thrombosis and haemostasis
|November 25, 2025
概括
识别不稳定的动脉斑块是预防缺血性中风的关键. 结合血液生物标志物和成像的新诊断策略可以个性化风险评估并改善中风预防.
科学领域:
- 神经学 神经学
- 心血管医学 心血管医学
- 生物标志物 生物标志物
背景情况:
- 缺血性中风每年影响数以百万计的患者,其中动脉斑块的血栓形成是主要原因.
- 目前的方法难以识别不稳定的斑块,导致程序有效性适度.
- 需要个性化诊断来提高风险分层和预防中风.
研究的目的:
- 审查识别不稳定的动脉斑块的科学进展.
- 讨论改善患者选择和预防中风的策略.
- 突出综合诊断方法的潜力.
主要方法:
- 关于斑块不稳定性和诊断生物标志物的科学文献的综述.
- 分析成像方法 (MRI,CTA,超声波) 用于病变的识别.
- 讨论将基于血液和成像的生物标志物与系统生物学建模的整合.
主要成果:
- 斑块的不稳定性与核心扩大,炎症,新血管化和帽子变薄有关.
- 缺氧驱动的血管生成和斑块内出血导致不稳定.
- 循环中的生物分子和先进的成像表型可以信号迫在眉的风险.
结论:
- 将血液生物标志物与定量成像相结合,提供了个性化的诊断管道.
- 这种方法可以选循环不稳定信号,并定位罪祸首的病变.
- 基于精确风险评估的量身定制疗法可以减少不必要的手术,提前预防中风.
更多相关视频
相关概念视频
Atherosclerosis I: Introduction
835
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
835
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
444
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
444
Atherosclerosis IV: Nursing Management
351
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
351
Atherosclerosis III: Management
301
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
301
Coronary Artery Disease II: Pathophysiology
348
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
348
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.1K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.1K


